Breast Cancer

, Volume 7, Issue 1, pp 99–103 | Cite as

Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer

  • Masatoshi Ohta
  • Yutaka Tokuda
  • Yuki Saitoh
  • Yasuhiro Suzuki
  • Akira Okumura
  • Mitsuhiro Kubota
  • Hiroyasu Makuuchi
  • Tomoo Tajima
  • Seiei Yasuda
  • Akira Shohtsu
Original Article

Abstract

Purpose

In primary breast cancer, axillary nodal status is the most powerful predictive factor of recurrence. However, axillary lymph node dissection may cause surgical complications. If preoperative evaluation of axillary lymph node metastases is possible, unnecessary axillary lymph node dissections can be avoided. The purpose of this study was to evaluate the efficacy of positron emission tomography (PET) on detection of axillary lymph node metastases in breast cancer.

Methods

PET scans of the axilla were obtained in 32 patients with primary breast cancer. All patients fasted for at least 4 hours before the examination. After transmission scans for attenuation correction were performed, emission scans after intravenous injection of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) were obtained.

Results

Overall accuracy of PET alone, ultrasonography alone, and in combination in the detection of axillary metastases were 82%, 79%, and 85% respectively.

Conclusion

There were no significant differences between PET, ultrasonography, and PET in combination with ultrasonography regarding sensitivity, specificity and accuracy in the detection of axillary metastases.

Key words

Breast cancer PET Axillary lymph node metastases 

Abbreviations

PET

Positron emission tomography

FDG

2-[l8F]-fluoro-2-deoxy-D-glucose

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Fisher B, Bauer M, Wickerham L,et al: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer; An NSABP update.Cancer 52:1551–1557, 1983.PubMedCrossRefGoogle Scholar
  2. 2).
    Pezner RD, Pattterson MP, Hill LR: Arm edema in patients treated conservatively for breast cancer; Relationship to patient’s age and axillary node dissection technique.Int J Radiat Oncol Biol Phys 12:2079–2083, 1986.PubMedGoogle Scholar
  3. 3).
    Assa J: The intercostobrachial nerve in radical mastectomy.J Surg Oncol 6:123–126, 1974.PubMedCrossRefGoogle Scholar
  4. 4).
    Warburg O: On the origin of cancer cells.Science 123:309–314, 1956.PubMedCrossRefGoogle Scholar
  5. 5).
    Kubota R, Kubota K, Yamada S,et al: Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.J Nucl Med 35:104–112, 1994.PubMedGoogle Scholar
  6. 6).
    Di Chiro G: Positron emission tomography using (18F) fluorodeoxy-glucose in brain tumors; A powerful diagnostic and prognostic tool.Invest Radiol 22:360–371, 1987.PubMedCrossRefGoogle Scholar
  7. 7).
    Rege S, Maass A, Chaiken L,et al: Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.Cancer 73:3047–3058, 1994.PubMedCrossRefGoogle Scholar
  8. 8).
    Laubenbacher C, Saumweber D, Wagener-Manslau C,et al: Comparison of fluorine-18-fluorodeoxy-glucose PET, MRI and endoscopy for staging of head and neck squamous-cell carcinomas.J Nucl Med 36:1747–1757, 1995.PubMedGoogle Scholar
  9. 9).
    Wahl RL, Quint LE, Greenough RL,et al: Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images; Preliminary prospective evaluation.Radiology 191:371–377, 1994.PubMedGoogle Scholar
  10. 10).
    Lewis P, Griffin S, Marsden P,et al: Whole-body 18F- fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.Lancet 344:1265–1266, 1994.PubMedCrossRefGoogle Scholar
  11. 11).
    Bares R, Klever P, Hauptmann S,et al: F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic cancer.Radiology 192:79–86, 1994.PubMedGoogle Scholar
  12. 12).
    Okada J, Yoshikawa K, Itami M,et al: Positron emission tomography using fluorine-18-fluorodeoxy-glucose in malignant lymphoma; A comparison with proliferative activity.J Nucl Med 33:325–329, 1992.PubMedGoogle Scholar
  13. 13).
    Griffeth LK, Dehdashti F, McGuire AH,et al: PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.Radiology 182:185–194, 1992.PubMedGoogle Scholar
  14. 14).
    Adler LP, Blair HF, Makley JT,et al: Noninvasive grading of musculoskeletal tumors using PET.J Nucl Med 32:1508–1512, 1991.PubMedGoogle Scholar
  15. 15).
    Wahl RL, Cody RL, Hutchins GD,et al: Primary and metastatic breast carcinoma; Initial clinical evaluation with PET with the radiolabeled glucose analog 2- [18F]-fluoro-2-deoxy-D-glucose.Radiology 179:765–770, 1991.PubMedGoogle Scholar
  16. 16).
    Adler LP, Crowe JP, Al-Kaisi NK,et al: Evaluation of breast masses and axillary lymph nodes with [F-18]- 2-deoxy-2-fluoro-D-glucose PET.Radiology 187:743–750, 1993.PubMedGoogle Scholar
  17. 17).
    Bombardieri E, Crippa F, Maffioli L,et al: Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer; Can positron emission tomography (PET) with18F-FDG be considered as the best method?Int J Oncol 8:693–699, 1996.Google Scholar
  18. 18).
    Holle LH, Trampert L, Lung-Kurt S,et al: Investigations of breast tumors with fluorine-18-fluorodeoxy- glucose and SPECT.J Nucl Med 15:61–66, 1996.Google Scholar
  19. 19).
    Kubota K, Matsuzawa T, Amemiya T,et al: Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography.J Comput Assist Tomogr 13:1097–1098, 1989.PubMedGoogle Scholar
  20. 20).
    Tse NY, Hoh CK, Hawkins RAet al: The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.Ann Surg 216:23–33, 1992.CrossRefGoogle Scholar
  21. 21).
    Wahl RL, Helvie MA, Chang AE,et al: Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-fluorodeoxyglucose-PET.J Nucl Med 35:872–875, 1994.PubMedGoogle Scholar
  22. 22).
    Pietrzyk U, Scheidhauer K, Scharl A,et al: Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging.J Nucl Med 36:1882–1884, 1995.PubMedGoogle Scholar
  23. 23).
    Scheidhauser K, Scharl A, Pietrzyk U,et al: Qualitative [18F]FDG positron emission tomography in primary breast cancer; Clinical relevance and practicability.Eur J Nucl Med 23:618–623, 1996.CrossRefGoogle Scholar
  24. 24).
    Wahl RL, Zasadny K, Helvie M,et al: Metabolic monitoring of breast cancer chemotherapy using positron emission tomography; Initial evaluation.J Clin Oncol 11:2101–2111, 1993.PubMedGoogle Scholar
  25. 25).
    Bassa P, Kim EE, Inoue T,et al: Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.J Nucl Med 37:931–938, 1996.PubMedGoogle Scholar
  26. 26).
    Greco M, Agresti R, Raselli R,et al: Axillary dissection can be avoided in selected breast cancer patients; Analysis of 401 cases.Anticancer Res 16:3913–3918, 1996.PubMedGoogle Scholar
  27. 27).
    Crippa F, Agresti R, Seregni E,et al: Prospective evaluation of fluorine-18-FDG PET in presurgical staging of axilla in breast cancer.J Nucl Med 39:4–8, 1998.PubMedGoogle Scholar
  28. 28).
    Utech CI, Young CS, Winter PF,et al: Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochem- istry.Eur J Nucl Med 23:1588–1593, 1996.PubMedCrossRefGoogle Scholar
  29. 29).
    Avril N, Dose J, Janicke F,et al: Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glu- cose.J Natl Cancer Inst 88:1204–1209, 1996.PubMedCrossRefGoogle Scholar
  30. 30).
    Pamilo M, Soiva M, Lavast EM,et al: Realtime ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients.J Ultrasound Med 8:115–120, 1989PubMedGoogle Scholar
  31. 31).
    Bruneton JN, Caramella E, Aubanel D,et al: Axillary lymph node metastases in breast cancer; Preoperative detection with US.Radiology 158:325–326, 1986PubMedGoogle Scholar
  32. 32).
    Mustonen P, Farin P, Kosunen O: Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer.Ann Chir Gynecol 79:15–18, 1990.Google Scholar
  33. 33).
    Tate JJT, Lewis V, Archer T,et al: Ultrasound detection of axillary lymph node metastases in breast cancer.Eur J Surg Oncol 15:139–141, 1989.PubMedGoogle Scholar
  34. 34).
    Smith IC, Ogston KN, Whitford P,et al: Staging of the axilla in breast cancer; Accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-D-glucose.Ann Surg 2:220–227, 1998.CrossRefGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2000

Authors and Affiliations

  • Masatoshi Ohta
    • 1
  • Yutaka Tokuda
    • 1
  • Yuki Saitoh
    • 1
  • Yasuhiro Suzuki
    • 1
  • Akira Okumura
    • 1
  • Mitsuhiro Kubota
    • 1
  • Hiroyasu Makuuchi
    • 1
  • Tomoo Tajima
    • 1
  • Seiei Yasuda
    • 2
  • Akira Shohtsu
    • 2
  1. 1.Department of SurgeryTokai University School of MedicineJapan
  2. 2.Himedic Imaging Center at Lake YamanakakoJapan

Personalised recommendations